e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Novel findings in paediatric respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Duration of initial antibiotic course is associated with recurrent relapse in protracted bacterial bronchitis
E. Grose-Hodge (Newcastle Under Lyme, United Kingdom), W. Carroll (Stoke on Trent, United Kingdom), N. Rainford (Liverpool, United Kingdom), C. Gamble (Liverpool, United Kingdom), F. Gilchrist (Newcastle Under Lyme, United Kingdom)
Source:
International Congress 2019 – Novel findings in paediatric respiratory infections
Session:
Novel findings in paediatric respiratory infections
Session type:
Poster Discussion
Number:
5002
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Grose-Hodge (Newcastle Under Lyme, United Kingdom), W. Carroll (Stoke on Trent, United Kingdom), N. Rainford (Liverpool, United Kingdom), C. Gamble (Liverpool, United Kingdom), F. Gilchrist (Newcastle Under Lyme, United Kingdom). Duration of initial antibiotic course is associated with recurrent relapse in protracted bacterial bronchitis. 5002
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Early recurrent exacerbation and exacerbation therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 841s
Year: 2006
Correlation between eradication of infecting organism on days 3-5 of antibiotic therapy and clinical cure in patients with acute exacerbations of chronic bronchitis (AECB)
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
7-day course of antibiotics had similar efficacy to prolonged course in severe community-acquired pneumonia: a propensity-adjusted analysis
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB)
Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD
Year: 2003
Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis
Source: Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021
Year: 2021
Mechanisms of persistence of
Streptococcus pneumoniae
following treatment of acute exacerbation of chronic bronchitis
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009
Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 928-933
Year: 2001
One-year follow up of patients hospitalized for acute exacerbation of COPD related to viral infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Duration of therapy in hospitalised patients with CAP
Source: Annual Congress 2007 - An international perspective of the management of hospitalised patients with community-acquired pneumonia
Year: 2007
Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia
Source: Annual Congress 2004 - SARS and other lower respiratory tract infections
Year: 2004
Pseudomonas infection and home oxygen therapy can increase readmission in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Management of COPD
Year: 2017
Comparative evaluation of fluoroquinolone efficiency in treatment of infectious acute attack of chronic obstructive bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 512s
Year: 2004
How often can we use short course therapy in patients with hospital-acquired pneumonia?
Source: Eur Respir J 2007; 30: Suppl. 51, 408s
Year: 2007
Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
Source: Eur Respir J 2009; 33: 282-288
Year: 2009
Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Bacterial profile of acute infectious exacerbations of chronic obstructive pulmonary disease requiring hospitalization in Greece
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
Presence of bacterial infection influences the severity of symptoms in acute COPD exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 261s
Year: 2002
Wheeze in preschool age is associated with pulmonary bacterial infection and resolves after antibiotic therapy
Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy
Year: 2012
The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 295s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept